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A few familial adenomatous polyposis studies have focused upon faecal sterols and bile acids but none has analysed the fecal
content of fatty acids. We report here ﬁndings of an observational study on 29 colectomized familial adenomatous polyposis
patients that describe the fecal content of fatty acids, and relate this to the proportions of fatty acids and levels of cyclooxygenase
mRNA expression in duodenal biopsies, levels of serum lipoproteins, and diet. In the ileostomy group separately (n = 12), the
fecal content of arachidonic acid was correlated negatively to the proportions of eicosapentaenoic acid and docosahexaenoic acid
in duodenal biopsies. Total serum-cholesterol was negatively correlated to the fecal content of saturates and monounsaturates.
The fecal palmitoleic acid/palmitic acid ratio was positively correlated to the levels of cyclooxygease-2 expression in duodenal
biopsies.In the ileal-pouch-anal anastomosis group separately (n = 17), signiﬁcant correlations were found between the fecal
contents of oleic acid, linoleic acid, and alpha-linolenic acid, and the proportions of myristic acid, oleic acid and eicosaenoic acid
in duodenal biopsies. Dietary monounsaturates were positively correlated to diﬀerent fecal fatty acids. Future studies should focus
on molecular mechanisms relevant to fatty acid metabolism, inﬂammation, and angiogenesis, in addition to nutrition.
1.Introduction
Familial adenomatous polyposis [1]a c c o u n tf o r1 %o f
colorectal cancers, and provides a model of APC inactivation
as an early genetic event for the approximately 80%–85%
of cancers that develop from sporadic polyps. Colorectal
cancers arising in patients with familial adenomatous
polyposis can be largely prevented by polyp surveillance and
prophylactic colectomy [2]. Total proctocolectomy with con-
structionofaconventionalileostomyorileoanalanastomosis
with preparation of an ileal pouch, has various eﬀects on the
function of the terminal ileum and the intestinal bacterial
ﬂora [3]. This may deteriorate cholesterol metabolism, as
absorptionofcholesterolinduodenumandjejunumrequires
micellar solubilization with bile acids, fatty acids, monoglyc-
erides, and phospholipids [3]. Hypothetically, ileal-pouch-
anal anastomosis and ileostomy patients might diﬀer with
regard to the presence of various fatty acids in feces and their
relationship to other reﬂections of lipoprotein metabolism,
but we found no previous study focusing upon this issue.
Dietary fatty acids are incorporated into blood and
tissues, and the fatty acid composition in these tissues are
often used as biomarkers of fat intake. Furthermore, the fecal
amount and composition of fatty acids reﬂect fat ingestion,
intestinal fatty acid absorption, and the activity of colonic
bacteria [4]. Although some of the discrepancies between2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
studies may be due to the use of diﬀerent methods to analyze
fatty acids, diﬀerences in diet, or the fact that assessments
have been performed in diﬀerent body compartments,
modiﬁcations in the metabolism of fatty acids have been
suggested in cancer patients [5, 6]. It is not clear at what
steps in the multistage carcinogenesis process a possible
distorted fatty acid metabolism occurs. Notably, if such
alterations occur in the development of carcinogenesis, this
may aﬀect the biological functions of essential fatty acids
and their derivates [5].
Very little is known about fatty acid metabolism in
familial adenomatous polyposis, although chemoprevention
aﬀecting the fatty acid derivates and the cyclooxygenase
enzymes is often administered to familial adenomatous
polyposis patients. Deregulation of the cyclooxygenase-2
pathway appears to aﬀect tumorigenesis via a number of
distinct mechanisms: promoting tumour maintenance and
progression, encouraging metastatic spread, and perhaps
even participating in tumour initiation [7]. Cyclooxygenase-
1 and -2 are the rate limiting enzymes in the synthesis of
prostaglandins and thromboxanes [8]. Arachidonic acid
is the main substrate for these enzymes, leading to the
synthesis of prostaglandins which have growth promoting
eﬀects. Substituting arachidonic acid with omega-3 fatty
acids has been shown to lead to the production of less
potent prostaglandins [9]. Since cyclooxygenase-2 is a
fatty acid metabolising enzyme, the relationships between
cyclooxygenase-2 and fatty acid composition of diﬀerent
tissues is of interest. Colectomized familial adenomatous
polyposis patients had a deviant fatty acid proﬁle with high
levels of arachidonic acid and docosahexaenoic acid and low
levelsoflinoleicacidandalpha-linolenicacidinserumphos-
pholipids, which is in accordance with studies in patients
with other types of cancers [5, 10–13]. In a previous familial
adenomatous polyposis study [14], comparable treatment
eﬀects of a cyclooxygenase-2 inhibitor were observed on
the fatty acid composition in serum phospholipids and
duodenal lesions, presumably and most importantly the
nonbeneﬁcial eﬀects involving essential fatty acids.
We report here ﬁndings from an observational study
in colectomized familial adenomatous polyposis patients.
The results describe the content of fatty acids in feces, and
relate this to the proportions of fatty acids and levels of
cyclooxygenase mRNA expression in duodenal biopsies,
diet, and levels of serum lipoproteins. Because the eﬀects of
ileostomy construction may diﬀer from that of ileal-pouch-
anal anastomosis because of scarcity of the bacterial ﬂora
and diﬀerent surface area of the terminal ileum [3], we did
separate analyses for these two groups. Previous familial
adenomatous polyposis studies have focused upon faecal
sterols and bile acids [15–17], but none has to the best of
our knowledge analysed the content of fatty acids in feces,
including very long chained fatty acids.
2.MaterialandMethods
2.1. Patients. Data from the present study are taken from
a randomized double-blind placebo-controlled intervention
study with a cyclooxygenase-2 inhibitor [12, 14, 18]. The
main aim was to compare the eﬀect of Rofecoxib treatment
on duodenal lesions (data in preparation). The present
study comprises data from baseline for only the patients
operated with ileal-pouch-anal anastomosis and ileostomy
(77% of total study group). Patients were recruited from
a Norwegian familial adenomatous polyposis registry. All
of them had been colectomized, and duodenal lesions
had been veriﬁed by endoscopy and histology. Biopsies
were taken partly from macroscopically normal mucosa,
partly from representative visible adenoma. Rikshospitalet
University Hospital is a highly specialized university hospital
with national responsibilities in the area of complicated
treatments, such as follow-ups on the Norwegian familial
adenomatous polyposis patients. Inclusion criteria were
veriﬁed familial adenomatous polyposis, colectomy, 18–70
years of age, and documented duodenal lesions graded as
Spigelman I, II, or III and the largest adenoma\10mm.
Exclusion criteria were indications for surgical treatment,
suspected or documented intestinal obstruction or stenosis,
patients unwilling or unable to adhere to protocol, known
cardiac failure requiring medical treatment, and pregnancy.
Allpatientswereonafreediet.Asfortheadenomassampled,
theywereallassessedhistologicallyasmild/moderatedyspla-
sia, all below 10mm and all ﬂat, located in the descending
part of the duodenum. No foci of cancer were found in any
of the lesions.
2.2. Determinations. Samples of feces were transferred to
tubes and mixed to make a homogeneous mass of which
100–200uL were used for lipid extraction by adding 50uL
butanol, 100μLH 2O, 1mL methanol, and 1mL chloroform.
After 10min under N2, the mixture was ﬁltered and the ﬁlter
washed with 1ml chloroform + 1mL chloroform/methanol
(2:1) + 0.8mL 0.73% NaCl. After mixing for 15s, the tubes
were centrifuged for 30min at 1000g. The upper phase was
discarded and the lower phase transferred to new tubes and
evaporatedunderN2 at65
◦Cusingaheatblock.Then0.4mL
0.5N NaOH in methanol was added and the solution kept
for 7min at 100
◦C under nitrogen.After cooling to room
temperature, 0.5mL 12% BF3 was added and the solution
kept for 10min at 100
◦C under nitrogen. After cooling to
room temperature, 1mL heptan was added under nitrogen,
and mixing for 30s, 1 mL of saturated NaCl solution was
added. After mixing, the solution was centrifuged for 10min
at 1000g, and the upper phase transferred to new tubes. The
extraction procedure was performed one more time. Finally,
the heptan was evaporated and 300μLh e x a na d d e db e f o r e
continuing with the gas chromatography procedure referred
to earlier [12].
2.3. HabitualDiet. Dietary intake was assessedby a validated
food frequency questionnaire, designed to cover as much of
the total habitual diet as possible. Questions were related
to habitual frequency of consumption and the amount of
foods eaten during the last year. They were asked to identify
their habitual choices of edible fats by pointing at specially
prepared pictures, in order to increase the validity of the
estimate of dietary fat [18].J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
2.4. RNA Isolation from Duodenal Lesions and Real-Time
Polymerase Chain Reaction. Lesions were taken and stored
in RNAlater solution previous to freezing at −80
◦C. Each
biopsy was put into a tube containing 600μLT r i z o la n d
immediately mixed on a MixerMill (Retsch GmbH, Ger-
many). RNA was isolated from the samples after standard
methods. Gene expression analyses were carried out on a
7900HT real-time PCR machine from Applied Biosystems.
Based on the results from running a housekeeping gene
test (“TaqMan Human Endogenous Control Plate,” Applied
Biosystems) with RNA from isolated human leucocytes (data
not shown). Tata binding protein (TBP) was chosen as
housekeeping gene. The primers and probes were initially
designed as three assays per gene and validated for eﬃciency
and speciﬁcity. The best of the three was then chosen. The
primers and probes for the COX-1 assay were: forward
primer: 5 -CTTCCAGGAGCTCGTAGGA-3 ,p r o b e :5  -
AGAAGGAGATGGCAGCAGAGTTGGAG-3 ,a n dr e v e r s e
primer: 5 -ACGCATCAATGTCTCCATACAAT-3 .C O X -
2f o r w a r dp r i m e r :5  -TGGAACATGGAATTACCCAGT-
3 ,p r o b e :5  -TGTTGAATCATTCACCAGGCAAATTGCT-
3 ,a n dr e v e r s ep r i m e r :5  -TCCTACCACCAGCAACCCT-
3 . GUS forward primer: 5 -GAAAATATGTGGTTGGAG-
AGCTCATT-3 ,p r o b e :5  -CCAGCACTCTCGTCGGTG-
ACTGTTCA-3 ,a n dr e v e r s ep ri m e r:5  -CCGAGTGAAGAT-
CCCCTTTTTA-3 . TBP forward primer: 5 -CTGGAAAAG-
TTGTATTAACAGGTGC-3 ,p r o b e :5  -AGCAGAAATTTA-
TGAAGCATTTGAAAACATCTACCCTATT-3 ,a n dr e v e r s e
primer: 5 -CATTACGTCGTCTTCCTGAATC-3 .
TaqMan Universal PCR Master Mix (Applied Biosys-
tems) was added as reaction mix. The reaction conditions
wereinitiatedbyastepof2min.at50
◦Cand10min.at95
◦C,
followed by 40 cycles of denaturation at 95
◦Cf o r1 5s e c .
and annealing at 60
◦C for 1min. Standards and samples was
analyzed in triplicates for all assays. A combination of cDNA
fromseveralsamplesweremadeanddilutedinordertomake
a dilution curve that was included on each plate. The average
of the three values for each gene was divided by the average
of the corresponding TBP values, generating a normalized
value of the gene expression which is a unit less value used to
compare the relative amount of mRNA for each gene in the
diﬀerent samples.
2.5. EthicsApproval. Thestudy wasperformedinaccordance
with the Helsinki Declaration. Patients were informed by a
physician, and in addition thoroughly written information
was given to all patients. The protocol was explained to
the subjects that had to give their consent before inclusion.
No honorarium was oﬀered. Retrospective registration was
done on 02/13/09 at ClinicalTrials.gov. The study pro-
tocol (RH01/01) was approved by the Norwegian health
authorities and the Regional Committee of Medical Ethics
20/06/2002 (reference: S-02127).
2.6. Data Analysis. Nonparametrical statistical methods
were chosen, as some of the variables were skewed and the
number of observations limited. Median values with quar-
tiles are presented unless otherwise stated. Relations between
variables were investigated by using Spearman’s correlation
coeﬃcients (rho). All statistical analyses were performed
with the SPSS 12.0 and Excel software for Windows.
3. Results
3.1. Background Characteristics. Background characteristics
of the patients are given in Table 1. Age and fecal content of
palmitolic acid, linoleic acid, and arachidonic acid diﬀered
between the ileostomy and the ileal-pouch-anal anastomosis
patients (Table 1).
3.2. The Ileostomy Group. The content of linoleic acid in
feces correlated negatively to the proportion of eicosaenoic
acid in duodenal biopsies (r =− 0.6, P<. 05). The content
of arachidonic acid in feces was correlated negatively to the
proportions of eicosapentaenoic acid (r =− 0.7, P = .02)
and docosahexaenoic acid (r =− 0.7, P = .008) in duodenal
biopsies. Total cholesterol were negatively correlated to the
content of palmitic acid (r =− 0.7, P = .03), palmitoleic
acid (r =− 0.7, P = .02), stearic acid (r =− 0.7, P = .02),
oleic acid (r =− 0.7, P = .02), linoleic acid (r =− 0.8,
P = .002), and monounsaturated fatty acids (r =− 0.7,
P = .02) in feces. The levels of triglycerides was negatively
correlatedtothecontentoflinoleicacid(r =− 0.8,P = .003)
and eicosaenoic acid (r =− 0.7, P = .03) in feces. No
signiﬁcant correlations were found between the content of
diﬀerent fatty acids in feces and the fatty acid dietary intake
(data not shown).
With the exception of the palmitoleic acid/palmitic acid
ratio and levels of cyclooxygenase-2 expression in duodenal
biopsies (r = 0.8, P = .003), no relationships were found
between fatty acids in feces and the levels of cyclooxygenase
mRNA expression (Figure 1).
3.3. The Ileal-Pouch-Anal Anastomosis Group. Signiﬁcant
correlations were found between the content of oleic acid
in feces and the proportion of myristic acid (r = 0.8, P<
.001), oleic acid (r = 0.5, P<. 05), and eicosaenoic acid
(r =− 0.5, P = .03) in duodenal biopsies. Moreover, the
content of linoleic acid in feces correlated signiﬁcantly to the
proportion of myristic acid (r = 0.8, P<. 001) in duodenal
biopsies, whereas the content of alpha-linolenic acid in feces
correlatedinverselytoeicosaenoicacid(r =− 0.6,P<. 05)in
duodenal biopsies. The content of palmitic acid in feces was
positively correlated to levels of LDL-cholesterol (r = 0.05,
P = .05). No signiﬁcant correlations were found between
the content of diﬀerent fatty acids in feces and the levels of
cyclooxygenasemRNAexpressioninduodenalbiopsies(data
not shown).
Several diﬀerent fatty acids in feces correlated posi-
tively to dietary intake of fatty acids, most predominantly
monounsaturated fatty acids (Table 2).
4. Discussion
A se x p e c t e d ,w ef o u n dad i ﬀerence between ileal-pouch-anal
anastomosis and ileostomy patients concerning associations
between fecal fatty acid composition and other variables4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
Table 1: Baseline characteristics and fecal composition of fatty acids in colectomized patients with familial adenomatous polyposis. Results
are presented as median and 25 and 75 percentiles.
Variables Ileostomy (n = 12) IPAA (n = 17) P value
Age, year 51 (36, 70) 36 (24, 61) .001
Age at colectomy, year 28 (19, 48) 21 (10, 45) .07
Body mass index, kg/m2 26.6 (19.8, 35.2) 25.5 (17.2, 30.8) .4
Dietary total fat (% of energy) 31 (27, 37) 30 (29, 36) .8
SAT 13 (11, 14) 11 (10, 13) .3
MUFA 10 (9, 12) 10 (9, 11) .5
PUFA 6 (5, 9) 7 (6, 9) .3
Total-cholesterol (mmol/L) 4.9 (4.2, 6.0) 4.7 (3.9, 5.6) .5
HDL-cholesterol (mmol/L) 1.8 (1.4, 2.1) 1.5 (1.3, 1.8) .1
LDL-cholesterol (mmol/L) 2.8 (2.4, 3.8) 3.3 (2.1, 3.9) .9
Triglycerides (mmol/L) 1.2 (0.9, 1.5) 1.0 (0.6, 1.5) .3
Fatty acids in feces (weight %):
Myristic acid 1.4 (0.9, 3.9) 1.1 (0.6, 1.4) .1
Palmitic acid 29.7 (26.1, 36.3) 32.7 (19.4, 38.4) .7
Palmitolic acid 1.1 (0.5, 1.5) 0.5 (0.3, 0.7) .003
Stearic acid 21.2 (13.8, 25.8) 28.1 (14.6, 36.5) .2
Oleic acid 18.9 (16.6, 31.4) 17.7 (12.6, 37.9) .9
Linoleic acid 16.7 (13.0, 25.3) 14.7 (10.7, 23.0) .4
Alpha-linolenic acid 1.6 (0.6, 2.8) 0.7 (0.2, 1.3) .04
Arachidonic acid 0.9 (0.4, 1.5) 0.2 (0.1, 0.8) .04
COX mRNA expression in duodenal biopsies
COX-1 0.86 (0.74, 0.95) 0.92 (0.83, 1.00) .1
COX- 2 1.11 (0.9, 1.25) 1.02 (0.96, 1.22) .6
The values for eicosenoic acid and eicosadienoic acid are not shown, since these values were close to zero.
COX: cyclooxygenase; IPAA: ileal-pouch-anal anastomosis; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; SAT: saturated fatty
acids.
Table 2: Spearman correlation coeﬃcients (r) between fatty acid composition of feces and dietary fatty acids in colectomized familial
adenomatous polyposis patients operated with ileal-pouch-anal anastomosis.1
Fecal fatty acids
Dietary fatty acids Palmitic acid Palmitoleic acid Oleic acid EPA DHA Sum MUFAs
Oleic acid 0.5(∗)0 . 6 ( ∗) 0.6 0.2 0.2 0.5(∗)
Linoleic acid 0.5 0.5 (∗)0 . 5 ( ∗) 0.3 0.3 0.5(∗)
Arachidonic acid 0.3 0.2 0.5 0.6(∗)0 . 5 ( ∗)0 . 5
Sum MUFAs 0.5(∗)0 . 6 ( ∗) 0.4 0.2 0.2 0.5(∗)
∗Correlation is signiﬁcant at the 0.05 level (2-tailed).
1No signiﬁcant coeﬃcients of correlation were seen for the ileostomy group.
The values for eicosenoic acid and eicosadienoic acid are not shown, since these values were close to zero.
DHA: docosahexaenoic acid; EPA: eicosapentaenoic acid; MUFA: monounsaturated fatty acids.
involved in lipoprotein metabolism. Possibly, our results
relate to metabolic diﬀerences caused by the diﬀerent
intestinal reconstructions, but the data are not suitable to
explain the ﬁndings.
We found no signiﬁcant relationships between the
levels of cyclooxygenase mRNA expression in duodenal
biopsies and the content of fatty acids in feces, except
for the estimates of the content of delta-9-desaturase
(stearoyl-CoA desaturase, SCD) activity, namely the ratio
of palmitolic acid/palmitic acid [19, 20] in the ileostomy
group. Stearoyl-CoA desaturase is the central lipogenic
enzyme catalyzing in vivo reactions in the synthesis of
monounsaturated fatty acids, particularly oleic acid and
palmitoleic acid, which are the major monounsaturated
fatty acids of membrane phospholipids, triglycerides, wax
esters, and cholesteryl esters. Both delta-9-desaurase and
cyclooxygenase-2 are PPAR alpha regulated, although this
possible link isonlya speculation.Astudyin healthysubjects
showed that human fecal water contains components can
aﬀect both the cyclooxygenase-2 protein level and enzymaticJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 5
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Figure 1: The scatterplot shows the ratios of palmitoleic
acid/palmiticacidinfecessamplesandthelevelsofcycooxygenase-2
expression in duodenal biopsies (ileostomy group, n = 12: r = 0.8,
P = .003; ileal-pouch-anal anastomosis group, n = 16: r =−0.2,
P = .5).
activity [21]. One recent study claims that it is possible
to detect cyclooxygenase-2 mRNA in feces of colorectal
cancer patients irrespective of clinical stage [22]. Notably,
increased cyclooxygenase-2 expression in duodenal com-
pared with colonic tissues in familial adenomatous polyposis
was recently reported [23].
The signiﬁcant negative correlation between content of
arachidonic acid in the feces and amounts of omega-3 fatty
acids in duodenal biopsies which was found in the ileostomy
group is interesting [24], since substitution of arachidonic
acid with omega-3 fatty acids has been shown to lead to
the production of less potent prostaglandins [9]. A previous
familial adenomatous polyposis study established a positive
correlation between the reduction in tissue prostanoid levels
and clinical response, as measured by the reduction in
size and number of adenomas, when patients were treated
with sulindac [25]. However, this correlation only became
consistently signiﬁcant when prostanoids were assayed after
tissue homogenates were ﬁrst incubated with arachidonic
acid [25]. We may suspect transformation of linoleic acid
to arachidonic acid in feces, but data are limited as with
regard to feces from colectomized familial adenomatous
polyposis subjects. The main dietary-source of arachidonic
acid is animal products. However, the dietary assessment
showed that the intake of such foods was normal among
these familial adenomatous polyposis patients [18].
Dietary controlled intervention studies on ileostomy
subjects have shown that dietary manipulation with fat and
ﬁber may modify cholesterol absorption and sterol excretion
[4]. In the ileostomy group, levels of total cholesterol
were negatively correlated to the content of palmitic acid,
palmitolic acid, stearic acid, oleic acid, linoleic acid, and
monounsaturated fatty acids (<1 8Ca t o m s )i nf e c e s ,w h i c h
is interesting since the present levels of total cholesterol are
lower than those among a healthy reference group [18].
In the ileal-pouch-anal anastomosis group separately, the
content of monounsaturated fatty acid in feces was positively
correlated to dietary intake of monounsaturated fatty acids
in particular. Moreover, positive correlations were found
between the content of oleic acid in feces and the proportion
of myristic acid, oleic acid, and eicosaenoic acid in duodenal
biopsies. The precise role of monounsaturated fatty acids
synthesis in cell proliferation and programmed cell death
remains unknown. The strong correlation of high levels of
monounsaturated fatty acids and neoplastic phenotype may
suggest that the regulation of stearoyl-CoA desaturase must
play a role in cancer development.
Thiswasanobservationalstudy,andnotametabolic bal-
ance study that was designed to investigate the metabolism
of fatty acids in familial adenomatous polyposis patients.
Although some studies have found that the absorption rate
of fatty acids are unaﬀected by age [26, 27], we cannot
exclude the possibility that some of the observed diﬀerences
between the ileal-pouch-anal anastomosis and ileostomy
patients might be due to age, rather than type of surgery,
since lipoprotein clearance has been shown to be altered
by age [28], and that might aﬀect the relationship between
dietary fatty acids and the fatty acid proﬁles found in
tissues. Moreover, no conclusions can be drawn from the
present study because this is an observational study. The
subgroup analyses were not designed a priori to detect these
diﬀerences. However, the study addresses the need to learn
more about the dietary and lifestyle habits of this subset
of at-risk patients. The present study includes a number of
patients close to the maximum possible number of eligible
Norwegianfamilialadenomatouspolyposispatients[12].We
may, however, suspect that the low sample size and use of a
food frequency questionnaire [14], may have weakened any
associations between the content of fatty acids in feces and
dietary intake. Notably, these data do not contradict that the
nutrient intake among these patients should at least meet
therecommendationsforhealthysubjects[18].Nevertheless,
we suggest that these data are compelling enough to suggest
that future familial adenomatous polyposis studies should
investigate overall fatty acid metabolism, molecular mecha-
nisms relevant to fatty acid metabolism, inﬂammation, and
angiogenesis, in addition to nutrition requirements.
In conclusion, we found a diﬀerence between ileal-
pouch-anal anastomosis and ileostomy patients concerning
associations between fecal fatty acid composition and other
variables involved in lipoprotein metabolism. We may sug-
gestthatfattyacidcontentinfecesisrelatedtodietaryintake,
serum lipids, and fatty acid composition in duodenal biop-
sies, even in colectomized familial adenomatous polyposis
patients. This observational study may represent hypothesis-
generating suggestions for future familial adenomatous
polyposis studies.6 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
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